Cargando…
Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report
Background: Primary central nervous system lymphomas (PCNSLs) are sensitive to chemotherapy. The standard treatment is high-dose methotrexate (MTX)-based chemotherapy. There are no reports of successful treatment of acute uric acid nephropathy with rasburicase after MTX administration in PCNSLs. Cas...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571497/ https://www.ncbi.nlm.nih.gov/pubmed/36233415 http://dx.doi.org/10.3390/jcm11195548 |
_version_ | 1784810377442230272 |
---|---|
author | Mouri, Yoshihiro Natsumeda, Manabu Okubo, Noritaka Sato, Taro Saito, Taiki Shibuya, Kohei Yamada, Shiori On, Jotaro Tsukamoto, Yoshihiro Okada, Masayasu Oishi, Makoto Eda, Takeyoshi Murai, Junko Shimizu, Hiroshi Kakita, Akiyoshi Fujii, Yukihiko |
author_facet | Mouri, Yoshihiro Natsumeda, Manabu Okubo, Noritaka Sato, Taro Saito, Taiki Shibuya, Kohei Yamada, Shiori On, Jotaro Tsukamoto, Yoshihiro Okada, Masayasu Oishi, Makoto Eda, Takeyoshi Murai, Junko Shimizu, Hiroshi Kakita, Akiyoshi Fujii, Yukihiko |
author_sort | Mouri, Yoshihiro |
collection | PubMed |
description | Background: Primary central nervous system lymphomas (PCNSLs) are sensitive to chemotherapy. The standard treatment is high-dose methotrexate (MTX)-based chemotherapy. There are no reports of successful treatment of acute uric acid nephropathy with rasburicase after MTX administration in PCNSLs. Case presentation: A 54-year-old man with a history of gout presented with a change in character and cognitive dysfunction. MRI showed a large enhancing mass spanning the bilateral frontal lobes and the right temporal lobe. After endoscopic biopsy, an MTX, procarbazine, and vincristine (MPV) regimen was initiated for the treatment of the PCNSL. After the initiation of chemotherapy, the patient experienced a gout attack, and blood examination revealed acute renal failure (ARF) and hyperuricemia. The considered causes of ARF included MTX toxicity and acute uric acid nephropathy. As the dramatic effect of MTX was observed, treatment was continued despite ARF, most probably due to acute hyperuricemia due to tumor lysis, which was treated in parallel. After an improvement in renal function, MTX was resumed, and rasburicase was initiated to control hyperuricemia. A complete response was obtained after induction chemotherapy. Hyperuricemia was controlled with rasburicase, and renal function was preserved. Conclusions: Acute uric acid nephropathy should be considered when ARF occurs after the initiation of MTX in PCNSLs, especially in newly diagnosed PCNSL patients with large tumors or hyperuricemia. |
format | Online Article Text |
id | pubmed-9571497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95714972022-10-17 Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report Mouri, Yoshihiro Natsumeda, Manabu Okubo, Noritaka Sato, Taro Saito, Taiki Shibuya, Kohei Yamada, Shiori On, Jotaro Tsukamoto, Yoshihiro Okada, Masayasu Oishi, Makoto Eda, Takeyoshi Murai, Junko Shimizu, Hiroshi Kakita, Akiyoshi Fujii, Yukihiko J Clin Med Case Report Background: Primary central nervous system lymphomas (PCNSLs) are sensitive to chemotherapy. The standard treatment is high-dose methotrexate (MTX)-based chemotherapy. There are no reports of successful treatment of acute uric acid nephropathy with rasburicase after MTX administration in PCNSLs. Case presentation: A 54-year-old man with a history of gout presented with a change in character and cognitive dysfunction. MRI showed a large enhancing mass spanning the bilateral frontal lobes and the right temporal lobe. After endoscopic biopsy, an MTX, procarbazine, and vincristine (MPV) regimen was initiated for the treatment of the PCNSL. After the initiation of chemotherapy, the patient experienced a gout attack, and blood examination revealed acute renal failure (ARF) and hyperuricemia. The considered causes of ARF included MTX toxicity and acute uric acid nephropathy. As the dramatic effect of MTX was observed, treatment was continued despite ARF, most probably due to acute hyperuricemia due to tumor lysis, which was treated in parallel. After an improvement in renal function, MTX was resumed, and rasburicase was initiated to control hyperuricemia. A complete response was obtained after induction chemotherapy. Hyperuricemia was controlled with rasburicase, and renal function was preserved. Conclusions: Acute uric acid nephropathy should be considered when ARF occurs after the initiation of MTX in PCNSLs, especially in newly diagnosed PCNSL patients with large tumors or hyperuricemia. MDPI 2022-09-22 /pmc/articles/PMC9571497/ /pubmed/36233415 http://dx.doi.org/10.3390/jcm11195548 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Mouri, Yoshihiro Natsumeda, Manabu Okubo, Noritaka Sato, Taro Saito, Taiki Shibuya, Kohei Yamada, Shiori On, Jotaro Tsukamoto, Yoshihiro Okada, Masayasu Oishi, Makoto Eda, Takeyoshi Murai, Junko Shimizu, Hiroshi Kakita, Akiyoshi Fujii, Yukihiko Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report |
title | Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report |
title_full | Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report |
title_fullStr | Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report |
title_full_unstemmed | Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report |
title_short | Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report |
title_sort | successful treatment of acute uric acid nephropathy with rasburicase in a primary central nervous system lymphoma patient showing a dramatic response to methotrexate—case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571497/ https://www.ncbi.nlm.nih.gov/pubmed/36233415 http://dx.doi.org/10.3390/jcm11195548 |
work_keys_str_mv | AT mouriyoshihiro successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT natsumedamanabu successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT okubonoritaka successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT satotaro successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT saitotaiki successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT shibuyakohei successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT yamadashiori successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT onjotaro successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT tsukamotoyoshihiro successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT okadamasayasu successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT oishimakoto successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT edatakeyoshi successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT muraijunko successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT shimizuhiroshi successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT kakitaakiyoshi successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport AT fujiiyukihiko successfultreatmentofacuteuricacidnephropathywithrasburicaseinaprimarycentralnervoussystemlymphomapatientshowingadramaticresponsetomethotrexatecasereport |